Business Context and Reporting Period
Molina Healthcare, Inc. (MOH) filed a Current Report on Form 8-K dated November 20, 2025. The filing reports the completion of a private debt offering and the execution of a new revolving credit facility.
Key Financial Metrics and Debt Structure
- Senior Notes Issuance: Completed a private offering of $850.0 million aggregate principal amount of 6.500% Senior Notes due 2031.
- Interest Terms: Notes bear interest at 6.500% per year, payable semi-annually in arrears starting August 15, 2026.
- Maturity Date: February 15, 2031.
- Debt Ranking: Senior unsecured obligations ranking pari passu with existing senior debt; structurally subordinated to subsidiary liabilities.
- Revolving Credit Facility: Entered into a new Credit Agreement replacing the prior facility dated June 8, 2020. The filing states terms are substantially similar to the prior agreement with covenant amendments favorable to the Company, but does not disclose the specific credit limit amount.
Material Changes Versus Prior Period
The filing does not provide comparative financial performance data (revenue, profit, or cash flow) as it is a transactional report rather than a periodic financial statement. The primary material change is the expansion of the Company's capital structure through the new $850 million note issuance and the refinancing of its revolving credit facility.
Guidance, Outlook, and Terms
- Optional Redemption: The Company may redeem Notes on or after December 15, 2027, at specified prices. Prior to this date, redemption is possible with a "make-whole premium."
- Change of Control: Holders have the right to require the Company to repurchase Notes upon a Change of Control at a price calculated per the Indenture.
- Registration Rights: The Company does not intend to register the Notes for resale under the Securities Act of 1933.
- Events of Default: The Indenture includes customary events of default, including cross-acceleration to certain other indebtedness.
Investor Verification Checklist
- Verify the specific principal amount and terms of the new Revolving Credit Facility in Exhibit 10.1, as the summary text does not state the facility size.
- Review the "make-whole premium" calculation methodology in the Indenture (Exhibit 4.1) to assess early redemption costs.
- Confirm the use of proceeds from the $850 million offering, which is not explicitly detailed in the summary text.
- Assess the impact of the 6.500% interest rate on the Company's future interest expense relative to current market rates.